Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Net Cash Flow (2021 - 2025)

Historic Net Cash Flow for Biofrontera (BFRI) over the last 5 years, with Q3 2025 value amounting to -$3.8 million.

  • Biofrontera's Net Cash Flow fell 14462.33% to -$3.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$8.0 million, marking a year-over-year decrease of 122787.98%. This contributed to the annual value of $4.5 million for FY2024, which is 12855.7% up from last year.
  • Biofrontera's Net Cash Flow amounted to -$3.8 million in Q3 2025, which was down 14462.33% from -$3.1 million recorded in Q2 2025.
  • Biofrontera's Net Cash Flow's 5-year high stood at $22.8 million during Q4 2021, with a 5-year trough of -$10.4 million in Q4 2022.
  • In the last 5 years, Biofrontera's Net Cash Flow had a median value of -$2.1 million in 2023 and averaged -$1.2 million.
  • As far as peak fluctuations go, Biofrontera's Net Cash Flow tumbled by 1262716.05% in 2023, and later soared by 24630.52% in 2024.
  • Over the past 5 years, Biofrontera's Net Cash Flow (Quarter) stood at $22.8 million in 2021, then plummeted by 145.37% to -$10.4 million in 2022, then skyrocketed by 79.88% to -$2.1 million in 2023, then surged by 246.31% to $3.0 million in 2024, then plummeted by 224.6% to -$3.8 million in 2025.
  • Its Net Cash Flow stands at -$3.8 million for Q3 2025, versus -$3.1 million for Q2 2025 and -$4.1 million for Q1 2025.